Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-14

FDA Approved: RIVAROXABAN — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' original ANDA for rivaroxaban, making a generic rivaroxaban available in the U.S. for approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)